Forge Investment Outlook Q2 2024Road to Recovery: Private Market Accelerates in Q1
Forge Investment Outlook Q2 2024
Trading
Data
Solutions
Insights
About
TriSalus Life Sciences is a biopharma company that specializes in treatment research and development for tumors of the liver and pancreas. TriSalus involves a team of clinicians and scientists who develop systemic immunotherapies to fight tumors through its developed drug delivery methods.
| Date | Funding Round | Funding Raised | Price per Share | Last Known Valuation |
|---|---|---|---|---|
| 10/5/2022 | Series B-2 | $15.32MM raised | $XXX.XX | $XXX.XX |
| 9/29/2021 | Series B-1 and B-3 | $40.64MM raised | $XXX.XX | $XXX.XX |
| 3/18/2021 | Series B | $85.22MM raised | $XXX.XX | $XXX.XX |
| 3/2/2017 | Series A-6 | $16.3MM raised | $XXX.XX | $XXX.XX |
| 12/2/2015 | Series A-4 and A-5 | $15.12MM raised | $XXX.XX | $XXX.XX |
| 11/7/2013 | Series A-2 and A-3 | $19.68MM raised | $XXX.XX | $XXX.XX |
| 7/6/2011 | Series A-1 | $6.53MM raised | $XXX.XX | $XXX.XX |
